title: Additional transporter characterization may lead to new pharmaceutical opportunities.
authors.affiliation: Small Molecular Pharmacology, Genentech Inc., South San Francisco, California 94080, USA. olafur@gene.com
authors.forename: O S
authors.initials: OS
authors.lastname: Gudmundsson
mesh_terms: D018435:ATP Binding Cassette Transporter, Subfamily B / Q000235:genetics / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism; D018432:Drug Resistance, Multiple; D019450:Genes, MDR / Q000235:genetics; D006801:Humans; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000235:genetics / Q000378:metabolism*; D010600:Pharmacology / Q000639:trends*
chemical_list: D018435:ATP Binding Cassette Transporter, Subfamily B; D000970:Antineoplastic Agents; D027425:ATP-Binding Cassette, Sub-Family C Proteins